#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal squamous cell carcinoma Thermal burn Neuroendocrine carcinoma Acute graft versus host disease in liver Eosinophilic oesophagitis Muscular dystrophy VEXAS syndrome Essential thrombocythaemia Scedosporium infection Acute promyelocytic leukaemia Acute lymphocytic leukaemia recurrent Kearns-Sayre syndrome Glomerulonephritis membranoproliferative Cystic fibrosis respiratory infection suppression Short-bowel syndrome More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Treatment Cholangitis sclerosing Hairy cell leukaemia recurrent – Basic Information Waldenstrom’s macroglobulinaemia – Trials in Disease Sarcoidosis – Basic Information Mantle cell lymphoma stage IV – Basic Information Ehlers-Danlos syndrome – Treatment Congenital hypotransferrinaemia – Treatment Amyotrophic lateral sclerosis – Basic Information Lymphangiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Absk021 Hydrochloride Hydrate Olanzapine Metyrapone Bp Co-Trimoxazole Agomelatine Travoprost Bepranemab Heparin Sodium Ritonavir Atorvastatin Calcium Clofutriben Trimetazidine Dihydrochloride Ezetimibe OBI-821 Acenocoumarol Venlafaxine Hydrochloride AUR200 Izaflortaucipir (18F) Tazobactam Azd3427 More therapies…

    Learn about Your Condition

    Lymphangiosarcoma Nephropathy Choroid melanoma Cholangiosarcoma Hypersomnia Cirrhosis alcoholic Arthritis infective Adenomatous polyposis coli Ocular lymphoma Aicardi-Goutieres syndrome Renal impairment Aortic stenosis Hip arthroplasty Pulmonary sarcoidosis Vertigo More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Croix Rousse-Lyon

CHU Croix Rousse-Lyon

103 Grande Rue De La Croix Rousse, Lyon, 69317, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Hydroxychloroquine and Prednisone for Patients with Non-Severe Extra-Pulmonary Sarcoidosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sarcoidosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    • Prednisone
    France

  • Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Alpha-1 antitrypsin deficiency
    Investigated Drugs:
    • Fazirsiran
    • Saline
    Austria Belgium Czechia Denmark France Germany +7

  • Study on the Effects of Rifampicin, Amoxicillin, and Moxifloxacin in Treating Prosthetic Joint Infections Caused by Cutibacterium acnes for Affected Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Amoxicillin
    • Clindamycin
    • Doxycycline
    France

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Brain abscess
    Investigated Drugs:
    • Amoxicillin
    • Cefotaxime
    • Ceftriaxone Sodium
    Denmark France The Netherlands Sweden

  • Study on Linezolid and Vancomycin for Preventing Surgical Site Infections in Patients Undergoing Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vancomycin Hydrochloride
    • Linezolid
    • Vancomycin
    France

  • Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Drugs:
    • Efruxifermin
    Belgium Denmark France Germany Greece Italy +2

  • A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Austria Belgium Bulgaria France Germany Greece +4

  • Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Austria Belgium Bulgaria France Germany Greece +4

  • A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Letrozole
    Austria Belgium Czechia France Germany Greece +7

  • Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Elacestrant
    • Anastrozole
    • Exemestane
    Belgium Cyprus France Germany Greece Ireland +5
Previous Page
1 … 3 4 5 6 7 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!